Send to

Choose Destination
Neuromuscul Disord. 1995 Jul;5(4):291-5.

Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer.

Author information

Department of Neuromuscular Diseases, Istituto Nazionale Neurologico C. Besta, Milan, Italy.


We report our experience on myoblast transplantation in three Duchenne muscular dystrophy patients. Pure myoblasts (55 x 10(6) per patient) from HLA-matched donors, were injected into a tibialis anterior and the controlateral muscle was sham injected. Three months after transplantation, biopsies from the injected muscles were negative for dystrophin expression by immunocytochemistry. Reverse transcriptase-PCR (RT-PCR) failed to amplify any fragments of the deleted regions. This result confirms that myoblast transplantation is feasible, although the efficacy of this therapeutic approach is poor.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center